Suven Pharmaceuticals Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Suven Pharmaceuticals Limited generated cash of $3,584,831,000, which is less than the previous year. Cash used in financing activities reached the amount of -$138,023,000 last year. Net change in cash is therefore -$175,716,000.
Cash Flow
| 2020 | 4.15B | -4.21B | 63.67M |
|---|---|---|---|
| 2021 | 3.83B | -3.11B | -765.52M |
| 2023 | 4.50B | -1.94B | -2.35B |
| 2024 | 3.58B | -3.62B | -138.02M |
SUVENPHAR.NS Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 648.02M | 445.63M | 116.95M | 109.02M |
Operating activities | ||||
Net income | 3.00B | 5.59B | 4.67B | 4.04B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 545.95M | 464.59M | 312.20M | 236.82M |
Stock-based compensation expense | 19.94M | 0 | 0 | 0 |
| Deferred income tax benefit | 19.94M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | -228.02M | 1.24B | 133.60M | 346.18M |
Inventories | 816.14M | -293.93M | -262.08M | -177.73M |
Accounts payable | -281.73M | -407.25M | 119.45M | 171.28M |
Cash generated by operating activities | 3.58B | 4.50B | 3.83B | 4.15B |
Investing activities | ||||
Purchases Of Investments | -3.13B | -44K | -2.00B | -3.25B |
Investments In Property Plant And Equipment | -517.86M | -2.85B | -1.10B | -994.14M |
Acquisitions Net | 0 | 720K | 336K | 1.34M |
Cash generated by investing activities | -3.62B | -1.94B | -3.11B | -4.21B |
Financing activities | ||||
Common Stock Issued | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | -2.03B | -254.56M | -767.22M |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | -63.51M | -263.68M | -415.33M | 0 |
Cash used in financing activities | -138.02M | -2.35B | -765.52M | 63.67M |
Net Change In Cash | -175.71M | 202.39M | -45.13M | 7.92M |
Cash at end of period | 472.31M | 648.02M | 71.82M | 116.95M |
| Data source | Data source | Data source | Data source |